Brief: Athersys Publishes Report Of Clinical Trial For Acute Respiratory Distress Syndrome Treatment

Athersys

30/11/2021 12:41

Nov 30 (Reuters) - Athersys Inc  ATHX.O :
    * REPORT OF PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING
MULTISTEM® CELL THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME
PUBLISHED IN INTENSIVE CARE MEDICINE
    * ATHERSYS INC - RESULTS SHOW THERAPY WAS WELL-TOLERATED AND
SUPPORT POTENTIAL BENEFITS IN MORTALITY
    * ATHERSYS INC - DATA POOLED FROM TWO INDEPENDENT STUDIES
PROVIDE
FURTHER EVIDENCE OF POTENTIAL CLINICALLY MEANINGFUL BENEFIT OF
MULTISTEM
    * ATHERSYS INC - MULTISTEM TREATMENT WAS WELL-TOLERATED IN
THIS
CLINICAL TRIAL
    * ATHERSYS INC - QOL OUTCOMES, ASSESSED BY EQ-5D-3L AT DAYS
28,
90, AND 365, SHOWED GREATER RECOVERY AMONG SURVIVORS WHO
RECEIVED MULTISTEM TREATMENT
    * ATHERSYS INC - LOWER ALL-CAUSE MORTALITY IN
MULTISTEM-TREATMENT
GROUP COMPARED TO PLACEBO GROUP

Source text for Eikon:  ID:nBw20TZyFa 
Further company coverage:  ATHX.O 

 ((Reuters.Briefs@thomsonreuters.com;))